No Data
No Data
Zhejiang NHU (SZSE:002001) Shareholders Will Want The ROCE Trajectory To Continue
Debon Securities: The third quarter of 2024 may mark the bottom of chemical profits, with a turning point in the capacity cycle.
In the third quarter, the industry gross margin was 16.22%, -0.35pct year-on-year, -1.12pct quarter-on-quarter; net income attributable to mother was 5.01%, -0.34% year-on-year, -1.29pct quarter-on-quarter.
Research reports in-depth analysis | swhy: Maintain a "shareholding" rating for zhejiang nhu, new materials planning project progressing smoothly.
Swhy research reports pointed out that Zhejiang Nhu (002001.SZ) third quarter performance met expectations, profits reached a record high, overseas equipment supply tightened again, new materials business progressed smoothly. The company's vitamins main products VA, VE, VC market average prices in the third quarter were 193.05, 124.48, 19.05 yuan/kg, respectively, with increases of 123.44%, 77.42%, 0% month-on-month. The recovery from the bottom of the economic cycle continued to drive the company's main performance growth. The company's projects progressed smoothly, with scale effects expected to continue to emerge. According to the company's announcement, the 0.15 million ton methionine plant process was successfully completed in one go.
Huafu Securities: BASF delays the resumption time of vitamins E and A production, prices are expected to continue to rise.
Due to the explosion, BASF delayed the reproduction time of vitamins E and A. After this news was announced, vitamins E and A quickly stopped falling and rebounded.
Zhejiang NHU Company Ltd. Just Beat EPS By 35%: Here's What Analysts Think Will Happen Next
Zhejiang NHU's Q3 Profit Surges 189%; Shares Fall 4%